## Abstract The Cbfa1/Runx2 is an important transcription factor necessary for osteoblast differentiation and bone formation. However, the signaling pathways regulating Runx2 activity are just beginning to be understood. Inconsistencies between Runx2 mRNA or protein levels and its transcriptional a
Osteoblast response to titanium regulates transcriptional activity of Runx2 through MAPK pathway
β Scribed by Kenji Hata; Kazunori Ikebe; Masahiro Wada; Takashi Nokubi
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 215 KB
- Volume
- 81A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Bone formation around an implant surface is indispensable for osseointegration of dental implants. Transcriptional factor Runx2 is essential for osteoblast differentiation and bone formation. However, little is known about the involvement of Runx2 in osseointegration. The purpose of this study was to investigate molecular interactions between Runx2 and implant titanium materials at the transcriptional level. Primary osteoblasts isolated from mouse calvaria and C3H10T1/2 cells were cultured on titanium plates or in the presence of titanium particles. Transcriptional activity of Runx2 was measured by reporter assay using osteocalcin gene promoter. We found significant increase (p < 0.05) in Runx2 transcriptional activity in cells cultured on titanium plates compared to plastic plates. Titanium particles also upregulated Runx2 transcriptional activity for over 2βfolds compared to control and this effect was abolished by the specific inhibitor for ERK1/2, PD98059. Moreover, treatment with PD98059 clearly suppressed osteoblast mineralization cultured on titanium plates. These data suggest that osteoblast attachment to titanium enhanced Runx2 transcriptional activity and bone formation via MAPK pathway during the osseointegration of dental implants. Β© 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2007
π SIMILAR VOLUMES
## Abstract ## Objective To analyze the effects of oncostatin M (OSM), a gp130βtype cytokine, on CCL2 expression in MGβ63 cells, a human osteosarcoma cell line with a characteristic osteoblastic phenotype, and to investigate the signaling pathway involved. ## Methods The expression of messenger